Vera Therapeutics (VERA) earnings, Aug 10, 2026: EPS −27%, stock −4.1%
In brief
Vera Therapeutics reported on Aug 10, 2026. Earnings per share changed −27% year over year, 3.5% above the estimate; revenue 0%. The stock opened with a +1.2% gap and closed the day −4.1% (Aug 11, 2026). The stock is now 46.2% below its 52-week high, +25.1% over 12 months. Next report: Nov 5, 2026.
EPS vs estimate+3.5%
EPS, YoY−27%
Revenue, YoY0%
Gap · day+1.2% · −4.1%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| May 7, 2026 | −0.3% | −2.0% |
| Aug 10, 2026 | +1.2% | −4.1% |
Next-quarter estimates, ratings and the VERA chart are in the terminal.
Open the terminalFAQ
When is Vera Therapeutics's next earnings report?
Nov 5, 2026. The date comes from daily data and is corrected if the company moves it.
How did Vera Therapeutics stock react to the report?
Opening gap +1.2%, day's result −4.1%.
Did Vera Therapeutics's earnings grow?
Earnings per share fell 27% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.